A detailed history of Global Financial Private Client, LLC transactions in Amgen Inc stock. As of the latest transaction made, Global Financial Private Client, LLC holds 1,628 shares of AMGN stock, worth $535,856. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,628
Previous 1,588 2.52%
Holding current value
$535,856
Previous $449 Million 13.17%
% of portfolio
0.21%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$262.75 - $319.31 $10,510 - $12,772
40 Added 2.52%
1,628 $509 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $42,212 - $50,955
157 Added 10.97%
1,588 $449 Million
Q4 2023

May 15, 2024

BUY
$255.7 - $288.46 $4,858 - $5,480
19 Added 1.35%
1,431 $412 Million
Q3 2023

May 15, 2024

BUY
$218.65 - $271.46 $20,334 - $25,245
93 Added 7.05%
1,412 $376 Million
Q2 2023

May 15, 2024

SELL
$214.27 - $253.37 $1,071 - $1,266
-5 Reduced 0.38%
1,319 $297 Million
Q4 2022

May 15, 2024

BUY
$229.03 - $291.01 $17,864 - $22,698
78 Added 6.26%
1,324 $348 Million
Q3 2022

May 15, 2024

BUY
$224.46 - $253.15 $79,683 - $89,868
355 Added 39.84%
1,246 $287 Million
Q2 2022

May 15, 2024

BUY
$230.71 - $256.74 $48,449 - $53,915
210 Added 30.84%
891 $219 Million
Q3 2021

May 15, 2024

BUY
$212.27 - $248.7 $63,681 - $74,610
300 Added 78.74%
681 $146 Million
Q3 2020

May 15, 2024

SELL
$234.65 - $260.95 $10,089 - $11,220
-43 Reduced 10.14%
381 $97.3 Million
Q1 2020

May 15, 2024

BUY
$182.24 - $241.7 $5,649 - $7,492
31 Added 7.89%
424 $83.9 Million
Q4 2019

May 15, 2024

BUY
$189.21 - $243.2 $74,359 - $95,577
393 New
393 $94.7 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $176B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Global Financial Private Client, LLC Portfolio

Follow Global Financial Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.